Neurotoxicity in lymphoblastic leukaemia: comparison of oral and intramuscular methotrexate and two doses of radiation.

Serial cranial computed tomograms were carried out in 136 children with acute lymphoblastic leukaemia who were receiving 24 Gy or 18 Gy of cranial irradiation and continuing treatment with doses of methotrexate given weekly orally or intramuscularly. The findings were correlated with treatment varia...

Full description

Bibliographic Details
Main Authors: Chessells, J, Cox, T, Kendall, B, Cavanagh, N, Jannoun, L, Richards, S
Format: Journal article
Language:English
Published: 1990
_version_ 1797077040646586368
author Chessells, J
Cox, T
Kendall, B
Cavanagh, N
Jannoun, L
Richards, S
author_facet Chessells, J
Cox, T
Kendall, B
Cavanagh, N
Jannoun, L
Richards, S
author_sort Chessells, J
collection OXFORD
description Serial cranial computed tomograms were carried out in 136 children with acute lymphoblastic leukaemia who were receiving 24 Gy or 18 Gy of cranial irradiation and continuing treatment with doses of methotrexate given weekly orally or intramuscularly. The findings were correlated with treatment variables, the development of fits, and the intelligence quotient (IQ). Reversible brain shrinkage, attributed to treatment with steroids, was found on 87 of 114 initial scans (76%); 14 showed changes in white matter during treatment (10%), and calcification was found in 13 either during or after treatment (10%). Eight children (6%) had fits, and in six of the eight there were changes in white matter or calcification on the scans. Comparison of the two radiotherapy dosages showed no difference in the incidence of abnormalities seen on computed tomography, fits, or serial IQ measurements, but children receiving intramuscular methotrexate had a higher incidence of calcification and a lower mean IQ at one year than those who received the drug orally, although this difference was not apparent later. Younger children were more likely to develop changes on computed tomograms and fits, and to have low IQs on completion of treatment, with changes most apparent in those less than 2 years of age. There were highly significant correlations between abnormalities on computed tomography, fits, and IQ. These findings confirm the neurological vulnerability of younger children with acute lymphoblastic leukaemia, show an association between abnormalities on computed tomography and intellectual deficit, and suggest that methotrexate is more toxic when given intramuscularly than orally. They provide no evidence that 18 Gy of cranial irradiation is less toxic than 24 Gy, and indicate the need for alternative treatment regimens.
first_indexed 2024-03-07T00:12:06Z
format Journal article
id oxford-uuid:7996aac4-8fac-464b-9a53-5633568e5f43
institution University of Oxford
language English
last_indexed 2024-03-07T00:12:06Z
publishDate 1990
record_format dspace
spelling oxford-uuid:7996aac4-8fac-464b-9a53-5633568e5f432022-03-26T20:38:19ZNeurotoxicity in lymphoblastic leukaemia: comparison of oral and intramuscular methotrexate and two doses of radiation.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:7996aac4-8fac-464b-9a53-5633568e5f43EnglishSymplectic Elements at Oxford1990Chessells, JCox, TKendall, BCavanagh, NJannoun, LRichards, SSerial cranial computed tomograms were carried out in 136 children with acute lymphoblastic leukaemia who were receiving 24 Gy or 18 Gy of cranial irradiation and continuing treatment with doses of methotrexate given weekly orally or intramuscularly. The findings were correlated with treatment variables, the development of fits, and the intelligence quotient (IQ). Reversible brain shrinkage, attributed to treatment with steroids, was found on 87 of 114 initial scans (76%); 14 showed changes in white matter during treatment (10%), and calcification was found in 13 either during or after treatment (10%). Eight children (6%) had fits, and in six of the eight there were changes in white matter or calcification on the scans. Comparison of the two radiotherapy dosages showed no difference in the incidence of abnormalities seen on computed tomography, fits, or serial IQ measurements, but children receiving intramuscular methotrexate had a higher incidence of calcification and a lower mean IQ at one year than those who received the drug orally, although this difference was not apparent later. Younger children were more likely to develop changes on computed tomograms and fits, and to have low IQs on completion of treatment, with changes most apparent in those less than 2 years of age. There were highly significant correlations between abnormalities on computed tomography, fits, and IQ. These findings confirm the neurological vulnerability of younger children with acute lymphoblastic leukaemia, show an association between abnormalities on computed tomography and intellectual deficit, and suggest that methotrexate is more toxic when given intramuscularly than orally. They provide no evidence that 18 Gy of cranial irradiation is less toxic than 24 Gy, and indicate the need for alternative treatment regimens.
spellingShingle Chessells, J
Cox, T
Kendall, B
Cavanagh, N
Jannoun, L
Richards, S
Neurotoxicity in lymphoblastic leukaemia: comparison of oral and intramuscular methotrexate and two doses of radiation.
title Neurotoxicity in lymphoblastic leukaemia: comparison of oral and intramuscular methotrexate and two doses of radiation.
title_full Neurotoxicity in lymphoblastic leukaemia: comparison of oral and intramuscular methotrexate and two doses of radiation.
title_fullStr Neurotoxicity in lymphoblastic leukaemia: comparison of oral and intramuscular methotrexate and two doses of radiation.
title_full_unstemmed Neurotoxicity in lymphoblastic leukaemia: comparison of oral and intramuscular methotrexate and two doses of radiation.
title_short Neurotoxicity in lymphoblastic leukaemia: comparison of oral and intramuscular methotrexate and two doses of radiation.
title_sort neurotoxicity in lymphoblastic leukaemia comparison of oral and intramuscular methotrexate and two doses of radiation
work_keys_str_mv AT chessellsj neurotoxicityinlymphoblasticleukaemiacomparisonoforalandintramuscularmethotrexateandtwodosesofradiation
AT coxt neurotoxicityinlymphoblasticleukaemiacomparisonoforalandintramuscularmethotrexateandtwodosesofradiation
AT kendallb neurotoxicityinlymphoblasticleukaemiacomparisonoforalandintramuscularmethotrexateandtwodosesofradiation
AT cavanaghn neurotoxicityinlymphoblasticleukaemiacomparisonoforalandintramuscularmethotrexateandtwodosesofradiation
AT jannounl neurotoxicityinlymphoblasticleukaemiacomparisonoforalandintramuscularmethotrexateandtwodosesofradiation
AT richardss neurotoxicityinlymphoblasticleukaemiacomparisonoforalandintramuscularmethotrexateandtwodosesofradiation